Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Greene John Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2025-06-05 Greene John Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2025-02-26 Greene John Director Purchase +7,000 $44.85 $314K 7,000
2024-05-30 Greene John Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2023-06-08 Greene John Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2022-06-09 Greene John Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2021-06-10 Greene John Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-11 Greene John Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2019-06-11 Greene John Director Grant or award · Stock Option (Right to Buy) +30,000 30,000

Page 1 of 1 · 9 trades